Journal profile · Urology & Nephrology
Advances in Chronic Kidney Disease
ISSN 1548-5595 · eISSN 1548-5609 · W.B. Saunders Ltd · UNITED STATES · Quarterly · Founded 2004
Advances in Chronic Kidney Disease: impact factor 0; hybrid open access; APC about USD 2,900; review 6–12 weeks (community reports); community-reported acceptance: fairly easy; indexed in Scopus.
Scope
Aims, scope and focus
Advances in Chronic Kidney Disease is published by W.B. Saunders Ltd. By OpenAlex counts of its recent articles, its largest topics are Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes and Diverse Scientific and Economic Studies, together about 31.6% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
The purpose of Advances Chronic Kidney Disease is to provide in-depth, scholarly review articles about the care and management of persons with early kidney disease and kidney failure, as well as those at risk for kidney disease. Emphasis is on articles related to the early identification of kidney disease; prevention or delay in progression of kidney disease
Source: LetPub
Research area (LetPub): Urology & Nephrology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dialysis and Renal Disease ManagementMedicine15%
- Chronic Kidney Disease and DiabetesMedicine8.4%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance8.2%
- Renal Diseases and GlomerulopathiesMedicine5.2%
- Marriage and Sexual RelationshipsSocial Sciences4.4%
- Human auditory perception and evaluationEngineering4.4%
- Educational Robotics and EngineeringComputer Science4.3%
- Ferroelectric and Negative Capacitance DevicesEngineering4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: yes
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0LetPub ·
- CiteScore 2026-06
- 5.9LetPub ·
- SJR 2026-06
- 0.97LetPub ·
- SNIP 2026-06
- 1.22LetPub ·
- h-index
- 57LetPub ·
- h-index
- 98OpenAlex ·
- i10-index
- 797OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 5.17%LetPub ·
Articles by year OpenAlex count · 1,731 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2022 | 87 | 19 | 582 |
| 2021 | 103 | 19 | 1,154 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,900 / EUR 2,540 / GBP 2,280 / JPY 311,650 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2004
- ISSN
- 1548-5595
- Electronic ISSN
- 1548-5609
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Advances in Chronic Kidney Disease
What is the impact factor of Advances in Chronic Kidney Disease?
The latest impact factor listed by LetPub is 0; CiteScore 5.9, h-index 98.
How long does peer review take at Advances in Chronic Kidney Disease?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Advances in Chronic Kidney Disease?
According to LetPub and DOAJ records, Advances in Chronic Kidney Disease is indexed in Scopus.
Is Advances in Chronic Kidney Disease open access, and what is the APC?
Advances in Chronic Kidney Disease is a hybrid journal. For open-access publication: APC about USD 2,900.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .